NCT05970783
A Study of Jincaopian Tablets on Chronic Pelvic Pain After Pelvic Inflammatory Disease
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below.
- Minor Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting
- Minor Primary completion date changed from estimate of Feb 2024 to Mar 11, 2024
- Study completion date: Nov 2024 to Apr 2025
- Site contact updated
- Study First Submitted
- Minor: routine updates
Endpoints
Primary
Pain disappearance rate after 12 weeks of treatment
Timeframe: 12 Weeks
Secondary (7)
Pain disappearance rate after 4 and 8 weeks of treatment
Change of weekly average Visual Analogue Scale (VAS) score from baseline after 12 weeks of treatment
The area under the VAS score-time curve
McCormick Scale
General quality of life (Short Form-12) scale
Show 2 moreShow less
Disease efficacy evaluation
Adverse events (AEs)
Arms and interventions
Jincaopian Tablets groupExperimental
Patients receive Jincaopian Tablets 0.6g/day for 12 weeks.
Placebo groupPlacebo comparator
Patients receive a placebo 0.6g/day for 12 weeks.
Drugs: Jincaopian Tablets
Other: Placebo
Sites
1 site in 1 country
- Beijing Hospital of Traditional Chinese Medicine affiliated to Capital Medical UniversityBeijing, Beijing Municipality, China